Sun Pharma Preview: Strong specialty biz, robust domestic sales to boost company’s health in Q4

The company#39;s specialty business is likely to post double-digit on-year growth in the quarter, despite some sequential moderation, according to brokerages.

Top 100 Best Sellers

Read More

​ The company#39;s specialty business is likely to post double-digit on-year growth in the quarter, despite some sequential moderation, according to brokerages. The company#39;s specialty business is likely to post double-digit on-year growth in the quarter, despite some sequential moderation, according to brokerages.  Moneycontrol Latest News Read More